Pharmacokinetics, Metabolism And Off-Target Effects In The Rat Of 8-[(1h-Benzotriazol-1-Yl)Amino]Octanoic Acid, A Selective Inhibitor Of Human Cytochrome P450 4z1: Beta-Oxidation As A Potential Augmenting Pathway For Inhibition

XENOBIOTICA(2021)

引用 1|浏览14
暂无评分
摘要
1. 8-[(1H-1,2,3-benzotriazol-1-yl)amino]octanoic acid (8-BOA) was recently identified as a selective and potent mechanism-based inactivator (MBI) of breast cancer-associated CYP4Z1 and exhibited favourable inhibitory activity in vitro, thus meriting in vivo characterization.2. The pharmacokinetics and metabolism of 8-BOA in rats was examined after a single IV bolus dose of 10 mg/kg. A biphasic time-concentration profile resulted in relatively low clearance and a prolonged elimination half-life.3. The major circulating metabolites identified in plasma were products of beta-oxidation; congeners losing two and four methylene groups accounted for >50% of metabolites by peak area. The -(CH2)(2) product was characterized previously as a CYP4Z1 MBI and so represents an active metabolite that may contribute to the desired pharmacological effect.4. Ex vivo analysis of total CYP content in rat liver and kidney microsomes showed that off-target CYP inactivation was minimal; liver microsomal probe substrate metabolism also demonstrated low off-target inactivation. Standard clinical chemistries provided no indication of acute toxicity.5. In silico simulations using the free concentration of 8-BOA in plasma suggested that the in vivo dose used here may effectively inactivate CYP4Z1 in a xenografted tumour.
更多
查看译文
关键词
Cytochrome P450 4Z1, mechanism-based inhibitor, bioactivation, breast cancer, rat, fatty acid, beta-oxidation, leaky hosepipe
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要